In vivo antimalarial activity and mechanisms of action of 4-nerolidylcatechol derivatives
Autor(a) principal: | |
---|---|
Data de Publicação: | 2015 |
Outros Autores: | , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional do INPA |
Texto Completo: | https://repositorio.inpa.gov.br/handle/1/15896 |
Resumo: | 4-Nerolidylcatechol (1) is an abundant antiplasmodial metabolite that is isolated from Piper peltatum roots. O-Acylation or O-alkylation of compound 1 provides derivatives exhibiting improved stability and significant in vitro antiplasmodial activity. The aim of this work was to study the in vitro inhibition of hemozoin formation, inhibition of isoprenoid biosynthesis in Plasmodium falciparum cultures, and in vivo antimalarial activity of several 4-nerolidylcatechol derivatives. 1,2-O,O-Diacetyl-4-nerolidylcatechol (2) inhibited in vitro hemozoin formation by up to 50%. In metabolic labeling studies using [1-(n)-3H]geranylgeranyl pyrophosphate, diester 2 significantly inhibited the biosynthesis of isoprenoid metabolites ubiquinone 8, menaquinone 4, and dolichol 12 in cultures of P. falciparum 3D7. Similarly, 2-O-benzyl-4-nerolidylcatechol (3) significantly inhibited the biosynthesis of dolichol 12. P. falciparum in vitro protein synthesis was not affected by compounds 2 or 3. At oral doses of 50 mg per kg of body weight per day, compound 2 suppressed Plasmodium berghei NK65 in infected BALB/c mice by 44%. This in vivo result for derivative 2 represents marked improvement over that obtained previously for natural product 1. Compound 2 was not detected in mouse blood 1 h after oral ingestion or in mixtures with mouse blood/blood plasma in vitro. However, it was detected after in vitro contact with human blood or blood plasma. Derivatives of 4-nerolidylcatechol exhibit parasite-specific modes of action, such as inhibition of isoprenoid biosynthesis and inhibition of hemozoin formation, and they therefore merit further investigation for their antimalarial potential. Copyright © 2015, American Society for Microbiology. All Rights Reserved. |
id |
INPA-2_97ac4458f23c1b074bc205b56aa6ec53 |
---|---|
oai_identifier_str |
oai:repositorio:1/15896 |
network_acronym_str |
INPA-2 |
network_name_str |
Repositório Institucional do INPA |
repository_id_str |
|
spelling |
Silva, Luiz Francisco Rocha eNogueira, Karla LagosPinto, Ana Cristina da SilvaKatzin, Alejandro MiguelSussmann, Rodrigo Antonio CeschiniMuniz, Magno PerêaAndrade Neto, Valter Ferreira deChaves, Francisco Célio MaiaCoutinho, Julia PennaLima, Emerson SilvaKrettli, Antoniana UrsineTadei, Wanderli PedroPohlita, Adrian Martin2020-05-19T21:03:18Z2020-05-19T21:03:18Z2015https://repositorio.inpa.gov.br/handle/1/1589610.1128/AAC.05012-144-Nerolidylcatechol (1) is an abundant antiplasmodial metabolite that is isolated from Piper peltatum roots. O-Acylation or O-alkylation of compound 1 provides derivatives exhibiting improved stability and significant in vitro antiplasmodial activity. The aim of this work was to study the in vitro inhibition of hemozoin formation, inhibition of isoprenoid biosynthesis in Plasmodium falciparum cultures, and in vivo antimalarial activity of several 4-nerolidylcatechol derivatives. 1,2-O,O-Diacetyl-4-nerolidylcatechol (2) inhibited in vitro hemozoin formation by up to 50%. In metabolic labeling studies using [1-(n)-3H]geranylgeranyl pyrophosphate, diester 2 significantly inhibited the biosynthesis of isoprenoid metabolites ubiquinone 8, menaquinone 4, and dolichol 12 in cultures of P. falciparum 3D7. Similarly, 2-O-benzyl-4-nerolidylcatechol (3) significantly inhibited the biosynthesis of dolichol 12. P. falciparum in vitro protein synthesis was not affected by compounds 2 or 3. At oral doses of 50 mg per kg of body weight per day, compound 2 suppressed Plasmodium berghei NK65 in infected BALB/c mice by 44%. This in vivo result for derivative 2 represents marked improvement over that obtained previously for natural product 1. Compound 2 was not detected in mouse blood 1 h after oral ingestion or in mixtures with mouse blood/blood plasma in vitro. However, it was detected after in vitro contact with human blood or blood plasma. Derivatives of 4-nerolidylcatechol exhibit parasite-specific modes of action, such as inhibition of isoprenoid biosynthesis and inhibition of hemozoin formation, and they therefore merit further investigation for their antimalarial potential. Copyright © 2015, American Society for Microbiology. All Rights Reserved.Volume 59, Número 6, Pags. 3271-3280Attribution-NonCommercial-NoDerivs 3.0 Brazilhttp://creativecommons.org/licenses/by-nc-nd/3.0/br/info:eu-repo/semantics/openAccess1,2 O,o Diacetyl 4 Nerolidylcatechol2 O Benzyl 4 NerolidylcatecholAntimalarial AgentCatechol DerivativeChloroquineDolicholHemozoinIsoprenoidMenatetrenoneNatural ProductQuinine SulfateUbiquinoneUnclassified Drug4 NerolidylcatecholAntimalarial AgentCatechol DerivativeAdultAnimals ExperimentAnimals ModelAntimalarial ActivityBiosynthesisBloodControlled StudyFemaleIn Vitro StudyIn Vivo StudyMalariaMetaboliteMouseNonhumanPlasmaPlasmodium BergheiPlasmodium FalciparumPriority JournalProtein SynthesisAnimalsBagg Albino MouseDrug EffectsMalaria, FalciparumMetabolismPathogenicityElectrophoresis, Polyacrylamide GelReverse Transcription Polymerase Chain ReactionAnimalAntimalarialsCatecholsElectrophoresis, Polyacrylamide GelFemaleMalaria, FalciparumMiceMice, Inbred Balb CPlasmodium BergheiPlasmodium FalciparumReverse Transcriptase Polymerase Chain ReactionIn vivo antimalarial activity and mechanisms of action of 4-nerolidylcatechol derivativesinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleAntimicrobial Agents and Chemotherapyengreponame:Repositório Institucional do INPAinstname:Instituto Nacional de Pesquisas da Amazônia (INPA)instacron:INPAORIGINALartigo-inpa.pdfartigo-inpa.pdfapplication/pdf667174https://repositorio.inpa.gov.br/bitstream/1/15896/1/artigo-inpa.pdf7a2eb35af995e1734eb7ef9a30e3fe36MD511/158962020-05-19 17:16:56.862oai:repositorio:1/15896Repositório de PublicaçõesPUBhttps://repositorio.inpa.gov.br/oai/requestopendoar:2020-05-19T21:16:56Repositório Institucional do INPA - Instituto Nacional de Pesquisas da Amazônia (INPA)false |
dc.title.en.fl_str_mv |
In vivo antimalarial activity and mechanisms of action of 4-nerolidylcatechol derivatives |
title |
In vivo antimalarial activity and mechanisms of action of 4-nerolidylcatechol derivatives |
spellingShingle |
In vivo antimalarial activity and mechanisms of action of 4-nerolidylcatechol derivatives Silva, Luiz Francisco Rocha e 1,2 O,o Diacetyl 4 Nerolidylcatechol 2 O Benzyl 4 Nerolidylcatechol Antimalarial Agent Catechol Derivative Chloroquine Dolichol Hemozoin Isoprenoid Menatetrenone Natural Product Quinine Sulfate Ubiquinone Unclassified Drug 4 Nerolidylcatechol Antimalarial Agent Catechol Derivative Adult Animals Experiment Animals Model Antimalarial Activity Biosynthesis Blood Controlled Study Female In Vitro Study In Vivo Study Malaria Metabolite Mouse Nonhuman Plasma Plasmodium Berghei Plasmodium Falciparum Priority Journal Protein Synthesis Animals Bagg Albino Mouse Drug Effects Malaria, Falciparum Metabolism Pathogenicity Electrophoresis, Polyacrylamide Gel Reverse Transcription Polymerase Chain Reaction Animal Antimalarials Catechols Electrophoresis, Polyacrylamide Gel Female Malaria, Falciparum Mice Mice, Inbred Balb C Plasmodium Berghei Plasmodium Falciparum Reverse Transcriptase Polymerase Chain Reaction |
title_short |
In vivo antimalarial activity and mechanisms of action of 4-nerolidylcatechol derivatives |
title_full |
In vivo antimalarial activity and mechanisms of action of 4-nerolidylcatechol derivatives |
title_fullStr |
In vivo antimalarial activity and mechanisms of action of 4-nerolidylcatechol derivatives |
title_full_unstemmed |
In vivo antimalarial activity and mechanisms of action of 4-nerolidylcatechol derivatives |
title_sort |
In vivo antimalarial activity and mechanisms of action of 4-nerolidylcatechol derivatives |
author |
Silva, Luiz Francisco Rocha e |
author_facet |
Silva, Luiz Francisco Rocha e Nogueira, Karla Lagos Pinto, Ana Cristina da Silva Katzin, Alejandro Miguel Sussmann, Rodrigo Antonio Ceschini Muniz, Magno Perêa Andrade Neto, Valter Ferreira de Chaves, Francisco Célio Maia Coutinho, Julia Penna Lima, Emerson Silva Krettli, Antoniana Ursine Tadei, Wanderli Pedro Pohlita, Adrian Martin |
author_role |
author |
author2 |
Nogueira, Karla Lagos Pinto, Ana Cristina da Silva Katzin, Alejandro Miguel Sussmann, Rodrigo Antonio Ceschini Muniz, Magno Perêa Andrade Neto, Valter Ferreira de Chaves, Francisco Célio Maia Coutinho, Julia Penna Lima, Emerson Silva Krettli, Antoniana Ursine Tadei, Wanderli Pedro Pohlita, Adrian Martin |
author2_role |
author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Silva, Luiz Francisco Rocha e Nogueira, Karla Lagos Pinto, Ana Cristina da Silva Katzin, Alejandro Miguel Sussmann, Rodrigo Antonio Ceschini Muniz, Magno Perêa Andrade Neto, Valter Ferreira de Chaves, Francisco Célio Maia Coutinho, Julia Penna Lima, Emerson Silva Krettli, Antoniana Ursine Tadei, Wanderli Pedro Pohlita, Adrian Martin |
dc.subject.eng.fl_str_mv |
1,2 O,o Diacetyl 4 Nerolidylcatechol 2 O Benzyl 4 Nerolidylcatechol Antimalarial Agent Catechol Derivative Chloroquine Dolichol Hemozoin Isoprenoid Menatetrenone Natural Product Quinine Sulfate Ubiquinone Unclassified Drug 4 Nerolidylcatechol Antimalarial Agent Catechol Derivative Adult Animals Experiment Animals Model Antimalarial Activity Biosynthesis Blood Controlled Study Female In Vitro Study In Vivo Study Malaria Metabolite Mouse Nonhuman Plasma Plasmodium Berghei Plasmodium Falciparum Priority Journal Protein Synthesis Animals Bagg Albino Mouse Drug Effects Malaria, Falciparum Metabolism Pathogenicity Electrophoresis, Polyacrylamide Gel Reverse Transcription Polymerase Chain Reaction Animal Antimalarials Catechols Electrophoresis, Polyacrylamide Gel Female Malaria, Falciparum Mice Mice, Inbred Balb C Plasmodium Berghei Plasmodium Falciparum Reverse Transcriptase Polymerase Chain Reaction |
topic |
1,2 O,o Diacetyl 4 Nerolidylcatechol 2 O Benzyl 4 Nerolidylcatechol Antimalarial Agent Catechol Derivative Chloroquine Dolichol Hemozoin Isoprenoid Menatetrenone Natural Product Quinine Sulfate Ubiquinone Unclassified Drug 4 Nerolidylcatechol Antimalarial Agent Catechol Derivative Adult Animals Experiment Animals Model Antimalarial Activity Biosynthesis Blood Controlled Study Female In Vitro Study In Vivo Study Malaria Metabolite Mouse Nonhuman Plasma Plasmodium Berghei Plasmodium Falciparum Priority Journal Protein Synthesis Animals Bagg Albino Mouse Drug Effects Malaria, Falciparum Metabolism Pathogenicity Electrophoresis, Polyacrylamide Gel Reverse Transcription Polymerase Chain Reaction Animal Antimalarials Catechols Electrophoresis, Polyacrylamide Gel Female Malaria, Falciparum Mice Mice, Inbred Balb C Plasmodium Berghei Plasmodium Falciparum Reverse Transcriptase Polymerase Chain Reaction |
description |
4-Nerolidylcatechol (1) is an abundant antiplasmodial metabolite that is isolated from Piper peltatum roots. O-Acylation or O-alkylation of compound 1 provides derivatives exhibiting improved stability and significant in vitro antiplasmodial activity. The aim of this work was to study the in vitro inhibition of hemozoin formation, inhibition of isoprenoid biosynthesis in Plasmodium falciparum cultures, and in vivo antimalarial activity of several 4-nerolidylcatechol derivatives. 1,2-O,O-Diacetyl-4-nerolidylcatechol (2) inhibited in vitro hemozoin formation by up to 50%. In metabolic labeling studies using [1-(n)-3H]geranylgeranyl pyrophosphate, diester 2 significantly inhibited the biosynthesis of isoprenoid metabolites ubiquinone 8, menaquinone 4, and dolichol 12 in cultures of P. falciparum 3D7. Similarly, 2-O-benzyl-4-nerolidylcatechol (3) significantly inhibited the biosynthesis of dolichol 12. P. falciparum in vitro protein synthesis was not affected by compounds 2 or 3. At oral doses of 50 mg per kg of body weight per day, compound 2 suppressed Plasmodium berghei NK65 in infected BALB/c mice by 44%. This in vivo result for derivative 2 represents marked improvement over that obtained previously for natural product 1. Compound 2 was not detected in mouse blood 1 h after oral ingestion or in mixtures with mouse blood/blood plasma in vitro. However, it was detected after in vitro contact with human blood or blood plasma. Derivatives of 4-nerolidylcatechol exhibit parasite-specific modes of action, such as inhibition of isoprenoid biosynthesis and inhibition of hemozoin formation, and they therefore merit further investigation for their antimalarial potential. Copyright © 2015, American Society for Microbiology. All Rights Reserved. |
publishDate |
2015 |
dc.date.issued.fl_str_mv |
2015 |
dc.date.accessioned.fl_str_mv |
2020-05-19T21:03:18Z |
dc.date.available.fl_str_mv |
2020-05-19T21:03:18Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://repositorio.inpa.gov.br/handle/1/15896 |
dc.identifier.doi.none.fl_str_mv |
10.1128/AAC.05012-14 |
url |
https://repositorio.inpa.gov.br/handle/1/15896 |
identifier_str_mv |
10.1128/AAC.05012-14 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.pt_BR.fl_str_mv |
Volume 59, Número 6, Pags. 3271-3280 |
dc.rights.driver.fl_str_mv |
Attribution-NonCommercial-NoDerivs 3.0 Brazil http://creativecommons.org/licenses/by-nc-nd/3.0/br/ info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Attribution-NonCommercial-NoDerivs 3.0 Brazil http://creativecommons.org/licenses/by-nc-nd/3.0/br/ |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Antimicrobial Agents and Chemotherapy |
publisher.none.fl_str_mv |
Antimicrobial Agents and Chemotherapy |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional do INPA instname:Instituto Nacional de Pesquisas da Amazônia (INPA) instacron:INPA |
instname_str |
Instituto Nacional de Pesquisas da Amazônia (INPA) |
instacron_str |
INPA |
institution |
INPA |
reponame_str |
Repositório Institucional do INPA |
collection |
Repositório Institucional do INPA |
bitstream.url.fl_str_mv |
https://repositorio.inpa.gov.br/bitstream/1/15896/1/artigo-inpa.pdf |
bitstream.checksum.fl_str_mv |
7a2eb35af995e1734eb7ef9a30e3fe36 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 |
repository.name.fl_str_mv |
Repositório Institucional do INPA - Instituto Nacional de Pesquisas da Amazônia (INPA) |
repository.mail.fl_str_mv |
|
_version_ |
1801499126678945792 |